Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SC3 Research Group
Pasadena, California, United Statessc3-research.com ↗
- Ownership
- Private
- Employees
- ~49
- Development stage
- Other
01
Overview
SC3 Research Group is an experienced neurology-focused clinical research enterprise conducting Phase 2–4 interventional studies. They operate as a clinical trial site supporting the development and evaluation of new treatments for neurodegenerative diseases such as multiple sclerosis and Parkinson’s disease. The company does not develop its own drugs but partners with sponsors to conduct trials at their Pasadena and Reseda clinics.
- Therapeutic areas
- Neurology
- Modalities
- Small moleculeBiologic
- Industry
- Contract Research Organization
Beyond the preview
Go deeper on SC3 Research Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SC3 Research Group.